SEARCH

SEARCH BY CITATION

References

  • Agca C., Fritz J. J., Walker L. C., Levey A. I., Chan A. W., Lah J. J. and Agca Y. (2008) Development of transgenic rats producing human beta-amyloid precursor protein as a model for Alzheimer’s disease: transgene and endogenous APP genes are regulated tissue-specifically. BMC Neurosci. 9, 28.
  • Ashe K. H. and Zahs K. R. (2010) Probing the biology of Alzheimer’s disease in mice. Neuron 66, 631645.
  • Baker H. F., Ridley R. M., Duchen L. W., Crow T. J. and Bruton C. J. (1994) Induction of beta (A4)-amyloid in primates by injection of Alzheimer’s disease brain homogenate. Comparison with transmission of spongiform encephalopathy. Mol. Neurobiol. 8, 2539.
  • Callahan M. J., Lipinski W. J., Bian F., Durham R. A., Pack A. and Walker L. C. (2001) Augmented senile plaque load in aged female beta-amyloid precursor protein-transgenic mice. Am. J. Pathol. 158, 11731177.
  • Clarke J., Thornell A., Corbett D., Soininen H., Hiltunen M. and Jolkkonen J. (2007) Overexpression of APP provides neuroprotection in the absence of functional benefit following middle cerebral artery occlusion in rats. Eur. J. Neurosci. 26, 18451852.
  • Echeverria V., Ducatenzeiler A., Alhonen L. et al. (2004) Rat transgenic models with a phenotype of intracellular Abeta accumulation in hippocampus and cortex. J. Alzheimers Dis. 6, 209219.
  • Eisele Y. S., Bolmont T., Heikenwalder M. et al. (2009) Induction of cerebral beta-amyloidosis: intracerebral versus systemic Abeta inoculation. Proc. Natl Acad. Sci. USA 106, 1292612931.
  • Eisele Y. S., Obermuller U., Heilbronner G. et al. (2010) Peripherally applied Aβ-containing inoculates induce cerebral β-amyloidosis. Science 330, 980982.
  • Flood D. G., Lin Y. G., Lang D. M., Trusko S. P., Hirsch J. D., Savage M. J., Scott R. W. and Howland D. S. (2009) A transgenic rat model of Alzheimer’s disease with extracellular Aβ deposition. Neurobiol. Aging 30, 10781090.
  • Folkesson R., Malkiewicz K., Kloskowska E. et al. (2007) A transgenic rat expressing human APP with the Swedish Alzheimer’s disease mutation. Biochem. Biophys. Res. Commun. 358, 777782.
  • Ghirardi O., Cozzolino R., Guaraldi D. and Giuliani A. (1995) Within- and between-strain variability in longevity of inbred and outbred rats under the same environmental conditions. Exp. Gerontol. 30, 485494.
  • Hardy J. and Selkoe D. J. (2002) The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 297, 353356.
  • Harvey B. K., Richie C. T., Hoffer B. J. and Airavaara M. (2011) Transgenic animal models of neurodegeneration based on human genetic studies. J. Neural Transm. 118, 2745.
  • Heuer E., Rosen R. F., Cintron A. and Walker L. C. (in press) Nonhuman primate models of Alzheimer-like cerebral proteopathy. Curr. Pharm. Des. [in press].
  • Hock B. J., Lattal K. M., Kulnane L. S., Abel T. and Lamb B. T. (2009) Pathology associated memory deficits in Swedish mutant genome-based amyloid precursor protein transgenic mice. Curr. Aging Sci. 2, 205213.
  • Holtzman D. M., Morris J. C. and Goate A. M. (2011) Alzheimer’s disease: the challenge of the second century. Sci. Transl. Med. 3, 77sr71.
  • Jucker M. (2010) The benefits and limitations of animal models for translational research in neurodegenerative diseases. Nat. Med. 16, 12101214.
  • Jucker M. and Walker L. C. (2011) Pathogenic protein seeding in Alzheimer’s disease and other neurodegenerative disorders. Ann. Neurol. 70, 532540.
  • Kane M. D., Lipinski W. J., Callahan M. J., Bian F., Durham R. A., Schwarz R. D., Roher A. E. and Walker L. C. (2000) Evidence for seeding of beta -amyloid by intracerebral infusion of Alzheimer brain extracts in beta -amyloid precursor protein-transgenic mice. J. Neurosci. 20, 36063611.
  • Langer F., Eisele Y. S., Fritschi S. K., Staufenbiel M., Walker L. C. and Jucker M. (2011) Soluble Aβ seeds are potent inducers of cerebral β-amyloid deposition. J. Neurosci. 31, 1448814495.
  • Leon W. C., Canneva F., Partridge V. et al. (2010) A novel transgenic rat model with a full Alzheimer’s-like amyloid pathology displays pre-plaque intracellular amyloid-beta-associated cognitive impairment. J. Alzheimers Dis. 20, 113126.
  • LeVine III H. and Walker L. C. (2006) Models of Alzheimer’s disease, in Handbook of Models for Human Aging (Conn P. M., ed.), pp. 121134. Academic Press, Burlington.
  • Liu L., Orozco I. J., Planel E. et al. (2008) A transgenic rat that develops Alzheimer’s disease-like amyloid pathology, deficits in synaptic plasticity and cognitive impairment. Neurobiol. Dis. 31, 4657.
  • Maclean C. J., Baker H. F., Ridley R. M. and Mori H. (2000) Naturally occurring and experimentally induced beta-amyloid deposits in the brains of marmosets (Callithrix jacchus). J. Neural Transm. 107, 799814.
  • Meyer-Luehmann M., Coomaraswamy J., Bolmont T. et al. (2006) Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host. Science 313, 17811784.
  • Morales R., Duran-Aniotz C., Castilla J., Estrada L. and Soto C. (2011) De novo induction of amyloid-beta deposition in vivo. Mol. Psychiatry doi: 10.1038/mp.2011.120. [Epub ahead of print].
  • Morrissette D. A., Parachikova A., Green K. N. and LaFerla F. M. (2009) Relevance of transgenic mouse models to human Alzheimer disease. J. Biol. Chem. 284, 60336037.
  • Mouton P. R. (2011) Unbiased Stereology: A Concise Guide. The Johns Hopkins University Press, Baltimore.
  • Otvos Jr L., Szendrei G. I., Lee V. M.-Y. and Mantsch H. H. (1993) Human and rodent Alzheimer beta-amyloid peptides acquire distinct conformations in membrane-mimicking solvents. Eur. J. Biochem. 211, 249257.
  • Paxinos G. and Watson C. (1998) The Rat Brain in Stereotaxic Coordinates, 4th edn. Academic Press, San Diego.
  • Ridley R. M., Baker H. F., Windle C. P. and Cummings R. M. (2006) Very long term studies of the seeding of beta-amyloidosis in primates. J. Neural Transm. 113, 12431251.
  • Rosen R. F., Farberg A. S., Gearing M. et al. (2008) Tauopathy with paired helical filaments in an aged chimpanzee. J. Comp. Neurol. 509, 259270.
  • Rosen R. F., Tomidokoro Y., Ghiso J. A. and Walker L. C. (2010) SDS-PAGE/immunoblot detection of Abeta multimers in human cortical tissue homogenates using antigen-epitope retrieval. J. Vis. Exp. e1916, doi: 10.3791/1916.
  • Ruiz-Opazo N., Kosik K. S., Lopez L. V., Bagamasbad P., Ponce L. R. and Herrera V. L. (2004) Attenuated hippocampus-dependent learning and memory decline in transgenic TgAPPswe Fischer-344 rats. Mol. Med. 10, 3644.
  • Sigurdsson E. M., Wisniewski T. and Frangione B. (2002) Infectivity of amyloid diseases. Trends Mol. Med. 8, 411413.
  • Soto C., Estrada L. and Castilla J. (2006) Amyloids, prions and the inherent infectious nature of misfolded protein aggregates. Trends Biochem. Sci. 31, 150155.
  • Tesson L., Cozzi J., Menoret S., Remy S., Usal C., Fraichard A. and Anegon I. (2005) Transgenic modifications of the rat genome. Transgenic Res. 14, 531546.
  • Walker L. C., Bian F., Callahan M. J., Lipinski W. J., Durham R. A. and LeVine H. (2002) Modeling Alzheimer’s disease and other proteopathies in vivo: is seeding the key? Amino Acids 23, 8793.
  • Walker L., Levine H. and Jucker M. (2006a) Koch’s postulates and infectious proteins. Acta Neuropathol. (Berl.) 112, 14.
  • Walker L. C., Levine 3rd H., Mattson M. P. and Jucker M. (2006b) Inducible proteopathies. Trends Neurosci. 29, 438443.
  • Watts J. C., Giles K., Grillo S. K., Lemus A., DeArmond S. J. and Prusiner S. B. (2011) Bioluminescence imaging of Abeta deposition in bigenic mouse models of Alzheimer’s disease. Proc. Natl Acad. Sci. USA 108, 25282533.
  • Wisniewski T. and Sigurdsson E. M. (2010) Murine models of Alzheimer’s disease and their use in developing immunotherapies. Biochim. Biophys. Acta 1802, 847859.